SCHEMBL5698641

SCHEMBL5698641

O=C(/C(=C/c1ccncc1)c1ccccc1)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.59
CYP11B2 P19099 1/20 0.59
AKR1C1 Q04828 2/20 0.56
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2D6 P10635 3/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
JAK2 O60674 1/20 0.47
TYK2 P29597 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698644 1.00 CYP19A1 (0.59) CYP19A1CYP11B2AKR1C1CYP1A2CYP3A4
SCHEMBL31406720 0.91 CYP19A1 (0.46) CYP19A1CYP11B2AKR1C1CYP1A2CYP3A4
SCHEMBL3863248 0.87 AKR1C1 (0.67) AKR1C1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL11219398 0.87 AKR1C1 (0.73) AKR1C1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL11219395 0.87 AKR1C1 (0.73) AKR1C1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3863246 0.87 AKR1C1 (0.67) AKR1C1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5698669 0.84 KMT2A (0.55) AKR1C1KMT2AMEN1ALDH1A1POLB
SCHEMBL5698662 0.84 KMT2A (0.55) AKR1C1KMT2AMEN1ALDH1A1POLB
SCHEMBL7176261 0.84 CYP19A1 (0.58) CYP19A1CYP11B2AKR1C1CYP1A2CYP3A4
SCHEMBL6076208 0.84 CYP19A1 (0.58) CYP19A1CYP11B2AKR1C1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed